196 related articles for article (PubMed ID: 23908135)
1. Design and synthesis of fluoroacylshikonin as an anticancer agent.
Kong WY; Chen XF; Shi J; Baloch SK; Qi JL; Zhu HL; Wang XM; Yang YH
Chirality; 2013 Nov; 25(11):757-62. PubMed ID: 23908135
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of heterocyclic carboxylic acyl shikonin derivatives.
Wang XM; Lin HY; Kong WY; Guo J; Shi J; Huang SC; Qi JL; Yang RW; Gu HW; Yang YH
Chem Biol Drug Des; 2014 Mar; 83(3):334-43. PubMed ID: 24118825
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of aryl dihydrothiazol acyl shikonin ester derivatives as anticancer agents through microtubule stabilization.
Lin HY; Li ZK; Bai LF; Baloch SK; Wang F; Qiu HY; Wang X; Qi JL; Yang RW; Wang XM; Yang YH
Biochem Pharmacol; 2015 Jul; 96(2):93-106. PubMed ID: 25957661
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of novel γ-carboline ketones as anticancer agents.
Chen J; Liu T; Wu R; Lou J; Dong X; He Q; Yang B; Hu Y
Eur J Med Chem; 2011 Apr; 46(4):1343-7. PubMed ID: 21342735
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
Mallavadhani UV; Prasad CV; Shrivastava S; Naidu VG
Eur J Med Chem; 2014 Aug; 83():84-91. PubMed ID: 24953027
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of cinnamic acyl shikonin derivatives.
Lin HY; Chen W; Shi J; Kong WY; Qi JL; Wang XM; Yang YH
Chem Biol Drug Des; 2013 Feb; 81(2):275-83. PubMed ID: 23066914
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors.
Wang YT; Qin YJ; Yang N; Zhang YL; Liu CH; Zhu HL
Eur J Med Chem; 2015 Jun; 99():125-37. PubMed ID: 26070164
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents.
Ruan BF; Lu X; Li TT; Tang JF; Wei Y; Wang XL; Zheng SL; Yao RS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):1113-21. PubMed ID: 22189271
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of naphthoquinone derivatives as antiproliferative agents and 20S proteasome inhibitors.
Xu K; Xiao Z; Tang YB; Huang L; Chen CH; Ohkoshi E; Lee KH
Bioorg Med Chem Lett; 2012 Apr; 22(8):2772-4. PubMed ID: 22437113
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel pyrazole derivatives with anticancer activity.
Balbi A; Anzaldi M; Macciò C; Aiello C; Mazzei M; Gangemi R; Castagnola P; Miele M; Rosano C; Viale M
Eur J Med Chem; 2011 Nov; 46(11):5293-309. PubMed ID: 21920636
[TBL] [Abstract][Full Text] [Related]
11. A potent anticancer agent of shikonin derivative targeting tubulin.
Baloch SK; Ma L; Xu GH; Bai LF; Zhao H; Tang CY; Pang YJ; Yang RW; Wang XM; Lu GH; Yang YH
Chirality; 2015 Mar; 27(3):274-80. PubMed ID: 25663187
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of sulfur-containing shikonin oxime derivatives as potential antineoplastic agents.
Huang G; Zhao HR; Meng QQ; Zhang QJ; Dong JY; Zhu BQ; Li SS
Eur J Med Chem; 2018 Jan; 143():166-181. PubMed ID: 29174813
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 1-benzylidene-3,4-dihydronaphthalen-2-one as a new class of microtubule-targeting agents.
Liu J; Zheng CH; Ren XH; Zhou F; Li W; Zhu J; Lv JG; Zhou YJ
J Med Chem; 2012 Jun; 55(12):5720-33. PubMed ID: 22676247
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and antiproliferative activity of 1,2-naphthoquinone and its derivatives.
Shukla S; Srivastava RS; Shrivastava SK; Sodhi A; Kumar P
Appl Biochem Biotechnol; 2012 Jul; 167(5):1430-45. PubMed ID: 22258648
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of benzoylacrylic acid shikonin ester derivatives as irreversible dual inhibitors of tubulin and EGFR.
Sun WX; Han HW; Yang MK; Wen ZL; Wang YS; Fu JY; Lu YT; Wang MY; Bao JX; Lu GH; Qi JL; Wang XM; Lin HY; Yang YH
Bioorg Med Chem; 2019 Dec; 27(23):115153. PubMed ID: 31648877
[TBL] [Abstract][Full Text] [Related]
16. Semi-synthesis and antitumor activity of 6-isomers of 5, 8-O-dimethyl acylshikonin derivatives.
Zhou W; Zhang X; Xiao L; Ding J; Liu QH; Li SS
Eur J Med Chem; 2011 Aug; 46(8):3420-7. PubMed ID: 21620530
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of benzimidazole carbamates bearing indole moieties for antiproliferative and antitubulin activities.
Guan Q; Han C; Zuo D; Zhai M; Li Z; Zhang Q; Zhai Y; Jiang X; Bao K; Wu Y; Zhang W
Eur J Med Chem; 2014 Nov; 87():306-15. PubMed ID: 25262051
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents.
Wang R; Zhang X; Song H; Zhou S; Li S
Bioorg Med Chem Lett; 2014 Sep; 24(17):4304-7. PubMed ID: 25127868
[TBL] [Abstract][Full Text] [Related]
19. Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents.
Santoshi S; Manchukonda NK; Suri C; Sharma M; Sridhar B; Joseph S; Lopus M; Kantevari S; Baitharu I; Naik PK
J Comput Aided Mol Des; 2015 Mar; 29(3):249-70. PubMed ID: 25481458
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumour activity of β-hydroxyisovalerylshikonin analogues.
Rao Z; Liu X; Zhou W; Yi J; Li SS
Eur J Med Chem; 2011 Sep; 46(9):3934-41. PubMed ID: 21689869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
